¥µ¥¤¥ÈÆâ´ØÏ¢¥Ú¡¼¥¸ °äÅÁÀ­¼À´µ¤â¤¯¤¸ OMIA¡¡1¡Á100 OMIA¡¡101¡Á200 OMIA¡¡201¡Á300 OMIA¡¡301¡Á400 OMIA¡¡401¡Á500
OMIA¡¡501¡Á600 OMIA¡¡601¡Á700 OMIA¡¡701¡Á SiriuDog 001¡Á070 SiriuDog 071¡Á140 SiriuDog 141¡Á210 SiriuDog 211¡Á280
SiriuDog 281¡Á334 ¡üʬÎàÊÌ-·ì´ÉÅù ¸¡ººµ¡´Ø°ìÍ÷ ¹ñÆâ°äÅÁ»Ò¸¡ººÉµ¤°ìÍ÷ ¹ñÆâ°äÅÁ»Ò¸¡ºº¸¤¼ïÊÌ °äÅÁÉÂÍѸì²òÀâ
¸¤¼ïḚ̂äÅÁÀ­¼À´µ(07ǯÅÙÅÐϿƬ¿ô½ç) 1°Ì¥À¥Ã¥¯¥¹¥Õ¥ó¥È 2°Ì¥Á¥ï¥ï 3°Ì¥×¡¼¥É¥ë 4°Ì¥è¡¼¥¯¥·¥ã¡¼¥Æ¥ê¥¢ 5°Ì¥Ý¥á¥é¥Ë¥¢¥ó


Dog Genetic disorder

2017ǯ9·î¸½ºß¤Ç707¼ï³Îǧ¤µ¤ì¤Æ¤¤¤ë¸¤¤Î°äÅÁ·Á¼Á¡¢°äÅÁÀ­¼À´µ
¤Î¤¦¤Á¡¢ÉÏ·ì¤ä·ì´É¤ËÉÂÊѤ¬½Ð¤ë¤â¤Î¤ä·ì±Õ¶Å¸Ç¾ã³²¤Ê¤É

ºîÀ®¡¡¡¡¡¡¡¡2006ǯ12·î
ºÇ½ª¹¹¿·¡¡¡¡2017ǯ9·î

¡¦OMIAOnline Mendelian Inheritance in Animals¡¡¸¤¤Î°äÅÁ·Á¼Á
http://omia.angis.org.au/
¥ê¥¹¥È¤ÎÉÂ̾¡¦ÂåɽŪ¤Ê¾É¾õ¡¦°äÅÁ·Á¼°¡¦¤è¤¯¸¦µæ¤µ¤ì¤Æ¤¤¤ë¸¤¼ï¤äưʪ¼ï¤ÎÏÂÌõ¤È¥á¥â

¡ü¤³¤Î¥Ú¡¼¥¸¤Î¾ðÊó¤ò»ÈÍѤ¹¤ëºÝ¤Ï°ìÉôʬ¤Ç¤¢¤Ã¤Æ¤âɬ¤º¤³¤³¤ÎURL¤òÌÀµ­¤·¤Æ¤¯¤À¤µ¤¤¡£¾ðÊó¤ÎÆÈ¤êÊ⤭¤Ë¤è¤ë¥È¥é¥Ö¥ëËɻߤΤ¿¤á¤Ç¤¹¡£
¡ü¸¡º÷¤«¤éľÀܤ³¤Î¥Ú¡¼¥¸¤ËÍ褿¾ì¹ç¤Ï¤ª¼ê¿ô¤Ç¤¹¤¬°äÅÁÀ­¼À´µ¤â¤¯¤¸¤ò°ìÅÙ¤´³Îǧ´ê¤¤¤Þ¤¹¡£
.
38
60 114 83 6 35 22 30 58 85 79 23 35 15 24
·Á¼Á ·ì´É¡¦·ì±Õ Ǿ¿À·Ð ¶Ú¹ü³Ê¡¦·ë¹çÁÈ¿¥ ¸ÆµÛ´ï ½Û´Ä´ï ¾Ã²½´ï ¿ÕǢϩ ÀèÅ·´ñ·Á ÆâʬÈ硦Âå¼Õ ´ã¡¦¼ª¡¦É¡ ¼ðáç ÈéÉæ ¥¢¥ì¥ë¥®¡¼¡¦Ì鱅 ¤½¤Î¾


·ì´É¡¦·ì±Õ¡¡¡¡¡¡¡¡¡¡60(1)
ÄÌÈÖ ¼À ´µ ̾ ¼ç ¤Ê ¾É ¾õ È÷¡¡¡¡¡¡¡¡¡¡¹Í °äÅÁ·ÁÂÖ ¼ç¤Ê³ºÅö¸¤¼ï
13 Afibrinogenemia
̵¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó·ì¾É
À¸¤Þ¤ì¤¿»þ¤ËçÁ¤Î½ï¤Î´¥¤­¤¬ÃÙ¤¤¡¢Ä̾ï¤Ï·Ú¤¤Èé²¼½Ð·ì¤äÉ¡·ì(Ç´ËìɽÌ̤«¤é¤Î)¡¢¼ê½Ñ¤ä²ø²æ¤ÇÂç½Ð·ì¡¢Í¢·ì¤â´Î±ê¤Ê¤É¤Î¥È¥é¥Ö¥ë Âè­µ°ø»Ò·ç˳¾É¡£·ì±ÕÃÁÇò¹çÀ®¾ã³²¡¢¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó¤È¤Ï´Î¡¤Çºî¤é¤ì¤ë·ì±Õ¶Å¸ÇÂè­µ°ø»Ò¡£
̵¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó·ì¾É¡Ê¥Û¥âÀܹç¡Ë¤Ç¤Ï½ÅÅٽз졣Äã¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó·ì¾É¤Ç¤Ï¼ê½Ñ¸å¤ËÁá´ü¤ÎºÇ¾®¸Â¤Î½Ð·ì¡£¼£ÎŤϥ¯¥ê¥ª¥×¥ì¥·¥Ô¥Æ¡¼¥È¤ÎÅêÍ¿
AR ¥Ó¥·¥ç¥ó¡¢¥Ü¥ë¥¾¥¤¡¢¥»¥ó¥È¥Ð¡¼¥Ê¡¼¥É
16 Alloimmune haemolytic anaemia of the newborn
*¿·À¸»ùƱ¼ïÌȱÖÍÏ·ìÀ­ÉÏ·ì
ºÇ½é¤Ë½éÆý¤ò¸ý¤Ë¤·¤Æ24¡Á27»þ´Ö°ÊÆâ¤ËÉϷ졦²«áÕ¡¦È¯Ç®¡¦¿¶ÀʢÄË¡¢¿·À¸»ù¤¬¿ôÆü°ÊÆâ¤Ë»àË´¤¹¤ë¤³¤È¤â ¿·À¸»ùÍÏ·ìÀ­¼À´µ¤È¤ÏÊì»Ò´Ö¤Î·ì±Õ·¿¤¬°Û¤Ê¤ë¾ì¹ç¤Ç¡¢²¿¤é¤«¤ÎÍýͳ¤ÇÂÛ»ù¤ÎÀÖ·ìµå¤¬ÊìÂÎÆâ¤ËÆþ¤ë¤ÈÊìÂΤǹ³ÂΤ¬¤Ä¤¯¤é¤ì¤ë¢ª¤½¤Î¹³ÂΤ¬½éÆý¤Ë¤è¤Ã¤Æ¿·À¸»ù¼«¿È¤ÎÀÖ·ìµå¤òÇ˲õ¤¹¤ë¡£´ØÏ¢¾ã³²*¥Ô¥ë¥Ó¥ó»À¥­¥Ê¡¼¥¼·ç˳¾É¡¡*¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì¡¡*Èóµå¾õÀ­¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì unknown *
59 Autoimmune thrombocytopenia
¼«¸ÊÌȱÖÀ­·ì¾®Èĸº¾¯¾É
·ì±Õ¶Å¸Ç¾ã³²¤«¤é¤Î̵µ¤ÎÏ¡¦¿©ÍßÉÔ¿¶¡¢ÈéÉæ¤äÇ´Ëì¤ÎÅÀ¾õ¡¦É½ºßÀ­½Ð·ì¡¢¿´Çï¿ôÁý²Ã¡¦¤¢¤¨¤®¸ÆµÛ¡¢½Å¾ÉÎã¤Ï¼º·ì»à ¼«Ê¬¤Î·ì¾®ÈĤËÂФ¹¤ë¹³·ì¾®ÈĹ³ÂΤ¬ºî¤é¤ì¤ë¤³¤È¤Ë¤è¤Ã¤Æ·ì¾®ÈÄ¿ô¤¬¸º¾¯¤¹¤ë(¼«Ê¬¤Î·ì¾®ÈĤò¹¶·â¤¹¤ë)¡£Ä̾ïÇò·ìµå¿ô¤ÈÀÖ·ìµå¿ô¤ÏÀµ¾ï¤Ç¹ü¿ñ¤Ç¤Ï·ì¾®ÈĤÎÁ°¶îºÙ˦¤Îµð³Ëµå¤¬Áý²Ã¤·¤Æ¤¤¤ë¡£¥á¥¹¤Ï¥ª¥¹¤Î3¡Á4ÇÜ¤ÎØí´µÎ¨ unknown ¿
64 Bleeding disorder
½Ð·ìÀ­¾ã³²
½ý¤Ê¤É¤Î½Ð·ìÎ̤¬Â¿¤¤¡¢¾®¤µ¤¯Àõ¤¤½ý¤«¤éÍÆ°×¤Ë½Ð·ì¡¢·ì¤¬»ß¤Þ¤ê¤Ë¤¯¤¤¡¢Æâ½Ð·ì¡¢É¡·ì¡¢¥á¥¹¤Îȯ¾ð½Ð·ì¤Î½Ð·ìÎ̤ȴü´Ö¤¬Â¿¤¤ ·ì±Õ¶Å¸Ç°ø»Ò¤ÎÀèŷŪ·ç˳¤Ë¤è¤ëɵ¤¤È¡¢¸åŷŪ¤Ê¸¶°ø¤Ë¤è¤ë·ì´É¾ã³²¡¦¶Å¸Ç°Û¾ï¤ÎÁí¾Î¡£·ìͧÉ¡¦¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ¡¦­»¡¡­¾¡¡­¾­µ¡¡­¾­¶¤Î¶Å¸Ç°ø»Ò·ç˳¾É¡¦Äãor̵¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó·ì¾É¡¢·ì¾®Èİ۾¥Ó¥¿¥ß¥óK·ç˳¾É¡¦´Î¼À´µ¤Ç¤ß¤é¤ì¤ë unknown ¿
65 Bleeding disorder due to P2RY12 defect
P2RY12·ç»½Ð·ìÀ­¼À´µ
·ì¾®ÈĶŸǰ۾ï Genes: P2RY12
ADP±þÅú¾ã³²¡¢½Ñ¸å½Ð·ì¾É¤È¤â¡£ P2RY12¤ÏP2RY¥Õ¥¡¥ß¥ê¡¼¤Ë°¤¹¤ë¼õÍÆÂΤǡ¢Ç¾¡¦ÀÔ¿ñ¡¦·ì¾®ÈĤ˹âȯ¸½¡©
AR ¥°¥ì¡¼¥È¥¹¥¤¥¹¥Þ¥¦¥ó¥Æ¥ó¥É¥Ã¥°
81 Budd-chiari syndrome
¥Ð¥Ã¥É¡¦¥­¥¢¥ê¾É¸õ·²
¶¯¤¤Ê¢ÄË¡¦Ê¢ÉôËÄËþ¡¦Ê¢Éô¤ÎÀÅÌ®¤¬É⤭½Ð¤ë¡¢Â¿°û¡¢¹â·ì°µ¡¢³±¡¢¸ÆµÛº¤Æñ¡¢Â®Ì®¡¢¼º¿À¡¢´Î¼À´µ ´ÎÀÅÌ®¤¢¤ë¤¤¤Ï´ÎÉô²¼ÂçÀÅÌ®¤ÎÊĺÉor¶¹ºõ¤Ë¤è¤ë¼À´µ¤ÇÀ¸¸å¿ôÆü¤«¤é¿ô¥ö·î¤Ç´ÎÉÔÁ´¤â¿¤¤¡¢4ºÐÁ°¤Þ¤Ç¤Ë¤Ïȯ¾É¤¹¤ë unknown ¥­¥ã¥Ð¥ê¥¢
110 Chronic myelogenous leukemia
ËýÀ­¹ü¿ñÀ­Çò·ìÉÂ
°×ÈèÏ«´¶¡¢ÈùÇ®¡¢°×´¶À÷¾É¡¢ÉÏ·ì¡¢Çò·ìµå¡¦·ì¾®ÈÄ¿ô¤ÎÁý²Ã ·ì±Õ¤Î¤¬¤ó unknown ¥´¥ë
112 Chylothorax
Æýäö¶»(¤Ë¤å¤¦¤Ó¤­¤ç¤¦)
¥ß¥ë¥¯¾õ¤Î±ÕÂΤ¬¶»Ëì¹ÐÆâ¤Ë¤¿¤Þ¤ëɵ¤ ¶»Éô¤Î¼çÍפʥê¥ó¥Ñ´É(¶»´É)¤Î»½ý¤ä¼ðáç(¤·¤å¤è¤¦)¤Ë¤è¤ë¥ê¥ó¥Ñ´É¤ÎÊĺɤ¬¸¶°ø¡¢¼£ÎŤ϶»´É·ë姤䥷¥ã¥ó¥È½Ñ¤Ê¤É³°²Ê¼ê½Ñ¡£¼ðáç¤ä¿¿¶Ý´¶À÷¾É¤ä¥Õ¥£¥é¥ê¥¢´¶À÷¤¬¸¶°ø¤È¤Ê¤ë¤³¤È¤â¤¢¤ë¤¬¸¤¤Ç¤Ï¿¤¯¤¬ÆÍȯÀ­¤Î¤è¤¦¤À
¢¨´ÉÍý¿Í¤Ï¸Ä¿ÍŪ¤ËÆýäö¶»¤òȯ¾É¤·¤¿¥ª¥ª¥«¥ß¸¤¡Ê¥Ï¥¤¥Ö¥ê¥Ã¥É¥¦¥ë¥Õ¥É¥Ã¥°¡¢¸¤¤È¥ª¥ª¥«¥ß¤Î»Ò¡¦¤Þ¤¿¤Ï¤µ¤é¤Ë¤½¤Î»Ò¤Ê¤É¡Ë¤òÃΤäƤ¤¤Þ¤¹¡£¤â¤Á¤í¤óÆüËÜ»º¡£¤À¤«¤é¡Ö¤è¤¯¸¦µæ¤µ¤ì¤Æ¤¤¤ë¸¤¼ï¡×¤ÎÆþÎϤ¬»þ¡¹¤à¤Ê¤·¤¯¤Ê¤ê¤Þ¤¹¢¨
¾ïÀ÷¿§ÂÎÀ­¡¢unknown Ç­
179 Diamond-Blackfan anaemia
¥À¥¤¥¢¥â¥ó¥É¡¦¥Ö¥é¥Ã¥¯¥Õ¥¡¥óÉÏ·ì
̵µ¤ÎÏ¡¢¿©ÍßÉÔ¿¶¡¢Ã¦ÎÏ´¶¡¢±¿Æ°ÉÔÂÑ¡¢¸µµ¤¾ÃÄÀ¡¢Ç´Ëì¤ÎÁóÇò ¤Ä¤Þ¤ê¤«¤Ê¤ê¤ª¤È¤Ê¤·¤¤¤³¤È¤¬¼ç¾É¾õ¤ÎÀèÅ·À­Äã·ÁÀ®À­ÉÏ·ì(ºÆÀ¸ÉÔÎÉÀ­ÉÏ·ì¤Î°ì¼ï)¡£ÀÖ·ìµå¤·ì¤Î¤ß¤¬¾ã³²¤µ¤ì¤ë¤·ìÉÔÁ´¾É¤ÇÀèÅ·À­ºÆÀ¸ÉÔÎÉÀ­ÉϷ졦ÀèÅ·À­ÀÖ²êµåáô(¤»¤ó¤Æ¤ó¤»¤¤¤»¤­¤¬¤­¤å¤¦¤í¤¦)¡£ÀÖ·ìµå·ÏºÙË¦Ãø¸º¡¢Ëö¾¿·ì¤ÏÌÖÀÖ·ìµå¸º¾¯¡£¥Ò¥È¤Î³ÎÄê¿ÇÃǤϹü¿ñÀü»É unknown(AD¤âAR¤â¡Ë *
183 Dwarfism with anaemia
¾®¿Í¾ÉÉÏ·ì
* ¥Õ¥¡¥ó¥³¥Ë¡¼¾É¸õ·²¡¢Æð¹ü̵·ÁÀ®¾É»²¾È unknown ¥Þ¥é¥ß¥å¡¼¥È
204 Elliptocytosis
ÂʱßÀÖ·ìµå¾É
ÉÏ·ì¤Þ¤¿¤ÏÍÏ·ì¤Þ¤¿¤ÏξÊý¤È磼𡢴Î磼ð ËìÃÁÇò¤Î°Û¾ï¤Çµ¯¤³¤êÀÖ·ìµå¤¬Âʱ߷¿¤â¤·¤¯¤ÏÍñ·¿¤Ç¡¢ÀÖ·ìµåɽÌÌÀѤ¬¸º¾¯¤¹¤ë¤¿¤áç£Â¡¤ÎÈù¾®½Û´Ä¤òÄ̲᤹¤ë¤Î¤ËɬÍפÊÀÖ·ìµå¤Î½ÀÆðÀ­¤¬Â»¤Ê¤ï¤ì¤Æ¤Îç£Â¡ÆâÍÏ·ì¡£
¿»Ø¤Ê¤É¤ÎÀèÅ·À­¹ü³Ê°Û¾ï¤¬È¼¤¦¤³¤È¤â¤¢¤ë
Genes: SPTB
AD *
218 Epistaxis
É¡½Ð·ì
É¡½Ð·ì 2005ǯ¤Î¥Î¡¼¥¹¥«¥í¥é¥¤¥ÊÂç³Ø¤ÎÄ´ºº¤ÇÉ¡½Ð·ì¤Î3³ä¤Î¸¤¤¬¥Ð¥ë¥È¥Í¥é¾É(Ç­¤Ò¤Ã¤«¤­ÉÂ)´¶À÷¤Ë´ØÍ¿¤·¤Æ¤¤¤¿Êó¹ð¤¬¤¢¤ë unknown *
225 Factor VII deficiency
Âè­»(¤À¤¤¤Ê¤Ê)°ø»Ò·ç˳¾É
¼ó¤«¤é¾å¤Î±ê¾É¤ä¼ð¤ì¡¢·ìƦ¾õ¤Î¤Ç¤­¤â¤Î¡¢½Ð·ì Gene: F7
°ÂÄê°ø»Ò·ç˳¾É¡£Âè­»°ø»Ò¤¬¶Ëü¤Ë·ç˳¤·¤¿¾õÂ֤ˤʤé¤Ê¤¤¸Â¤ê»à¤Ë»ê¤ë¤Û¤É½Å¾É¤Ê¥±¡¼¥¹¤ÏÈæ³ÓŪ¾¯¤Ê¤¤¡£·ì±Õ¶Å¸Ç¤Î¥×¥í¥»¥¹¤ò²Ã®¤¹¤ëÀ­¼Á¤ò»ý¤Ä¤¿¤ó¤Ñ¤¯¼Á¤Î·ç˳¤À¤¬¡¢¤¤¤Ä¤Î¤Þ¤Ë¤«²ø²æ¤ò¤·¤Æ¾¯Î̤νз줬¤¢¤ë¤¬¸¤¤¬µ¤¤Ë¤·¤Ê¤¤¤Ê¤ÉÌÀ¤é¤«¤Ê¾É¾õ¤¬½Ð¤Ë¤¯¤¯¡¢Æ°ÊªÉ±¡¤Ç¶öÁ³¤Ëȯ³Ð¤¹¤ë¤è¤¦¤Ê¥±¡¼¥¹¤¬Â¿¤¤¡£
·ì±ÕÃæ¤Î¶Å¸Ç°ø»Ò¤ÎÀèŷŪ¤Ê·ç˳(¤³¤¦¤¤¤Ã¤¿Éµ¤¤ÎÂåɽÎã¤Ï·ìͧÉÂ)¡£¶Å¸Ç°ø»Ò¤Ï12¼ïÎढ¤ê(Âè­º¤ò½ü¤¤¤ÆÂè­µ¤«¤éÂè­¾­·¤Þ¤Ç)¤½¤ÎÃæ¤Î¤É¤ì¤¬·ç˳¤·¤Æ¤¤¤ë¤«¤Ç¾É¾õ¤¬°ã¤¦¡£
AR ¥Ó¡¼¥°¥ë¡¢¥Ð¥»¥Ã¥È¡¢¥Þ¥é¥ß¥å¡¼¥È¡¢¥¨¥¹¥­¥â¡¼
226 Factor X deficiency
ÂèX(¤À¤¤¤¸¤å¤¦)°ø»Ò·ç˳¾É
Èæ³ÓŪ½ÅÅÙ¤ÎÆâ½Ð·ì(¤¢¤¶) ¥¹¥Á¥å¥¢¡¼¥È-¥×¥é¥¦¥¢¡¼°ø»Ò·ç˳¾É¡£¾É¾õ¤Ï·ÚÅÙ¤«¤é½ÅÅ٤ޤǸÄÂκ¹¤¬¤¢¤ë¤¬°ìÈ̤˷ìͧɤÈÈæ¤Ù¤ë¤È½Ð·ì¤Ï·ÚÅ٤ǡ¢¼ã¤¤¤Û¤É¥ê¥¹¥¯¤¬¹â¤¯¿·À¸»ù»àË´¤¬¤è¤¯¤¢¤ë¡£·ÚÅÙ¡ÁÃæÄøÅÙ¤ÇÀ®¸¤¤ËÀ®Ä¹¤·¤¿¸¤¤Ï¼ê½Ñ¤Ê¤ÉÆÃ¼ì¤Ê¾ì¹ç¤ò½ü¤­¤¢¤Þ¤ê½Ð·ì¤¬µ¯¤­¤Ê¤¤¤³¤È¤â¡£·ì±ÕÃæ¤ËÄ̾︺ߤ·¤Æ¤¤¤ë·ìÀò¤ò·ÁÀ®¤¹¤ë¤¿¤ó¤Ñ¤¯¼Á¤¬·ç˳¤¹¤ë¤³¤È¤Ë¤è¤ëÆâ½Ð·ì AR¤« A¥³¥Ã¥«¡¼¡¢E¥³¥Ã¥«¡¼¡¢¥¸¥ã¥Ã¥¯¡¢Â¾¥Æ¥ê¥¢¼ï
227 Factor XI deficiency
Âè­¾­µ(¤À¤¤¤¸¤å¤¦¤¤¤Á)°ø»Ò·ç˳¾É
³°½ý¤äÈ´»õ¡¢³°²Ê¼ê½Ñ¸å¤Î½Ð·ì²á¿ Gene: F11
·ìÞù¥È¥í¥ó¥Ü¥×¥é¥¹¥Á¥óÁ°¶îʪ¼Á(PTA)·ç˳¾É¡¢¥í¡¼¥¼¥ó¥¿¡¼¥ë¾É¸õ·²¡£½Ð·ì¤Ï¤·¤Ð¤·¤ÐÃ×̿Ū¡£·ì±Õ¤Î¶Å¸Ç¤ËɬÍפʤ¿¤ó¤Ñ¤¯¼Á¤Î·ç˳¤À¤¬Æâ½Ð·ì¡¦¼«Á³½Ð·ì¤Ï¤¢¤Þ¤ê¸«¤é¤ì¤Ê¤¤
AR¤« E¥¹¥×¡¢¥±¥ê¡¼¥Ö¥ë¡¼¡¢¥Ô¥ì
228 Factor XII deficiency
Âè­¾­¶(¤À¤¤¤¸¤å¤¦¤Ë)°ø»Ò·ç˳¾É
·ìÇ¢¡¢·ìÊØ¡¢ÅÇ·ì¡¢½Ð·ì»þ´Ö±äĹ ¥Ï¡¼¥²¥Þ¥ó°ø»Ò·ç˳¾É¡£ÅǤ·¤ãʪ¤äÇ¢¤äÊØ¤Ë·ì¤¬º®¤¸¤ëÄøÅÙ¤ÇÆâ½Ð·ì¤â¾¯¤Ê¤á¡¢²ø²æ¤Î»þ¤Ï·ì¤¬»ß¤Þ¤ê¤Ë¤¯¤¤¤«¤â¤·¤ì¤Ê¤¤¡£Â¾¤Î·ì±Õ¶Å¸Ç°ø»Ò¤Î·ç˳¾É¤È¤Ï°Û¤Ê¤ê¤è¤Û¤É¤ÎÂçÎ̽зì¤Ç¤â¤Ê¤±¤ì¤Ð½Ð·ì»à¤Î¥ê¥¹¥¯¤¬Äã¤á¤À¤¬¡¢·ì±ïÆâ(²È²À­)¤Ç¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ¡¦ÍÏ·ìÀ­ÉϷ졦¥×¥ì¥«¥ê¥¯¥ì¥¤¥ó·ç˳¾É¤Îȯ¾É¤Þ¤¿¤ÏƱ»þȯÀ¸¤ÎÎ㤢¤ê AR ¥×¡¼¥É¥ë¡¢¥Ð¥»¥ó¥¸¡¼¡¢C¥·¥ã¡¼¥Ú¥¤
271 Haemangiosarcoma
·ì´ÉÆù¼ð
½é´ü¤«¤éÃæ´ü¤Þ¤Ç¤Ï¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢²¼Î¡¤Ê¤É¤Î·Ú¤¤¾Ã²½´ï¾É¾õ¡¢Ëö´ü¤ËȽÊ̤Ǥ­¤ë¼ð¤ì¡¢ÉÏ·ì¤Ê¤É ·ì´É¤ÎÆâ¦¤Ë¤Ç¤­¤ë°­À­¼ðáç¤ÇÊ¿¶ÑŪ¤Êȯ¾ÉǯÎð¤Ï10ºÐÁ°¸å¡£¼ðáç¤ÎȯÀ¸¤Ïç£Â¡Éն᤬¿¤¯¿´Â¡¤Ëž°Ü¤¹¤ë¥±¡¼¥¹¤â¿¡£Í½¸åÉÔÎÉ unknown ¿
272 Haemolytic anaemia
ÍÏ·ìÀ­ÉÏ·ì
¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢²¼Î¡¡¢Ã¦ÎÏ´¶¤Ê¤É¤«¤é¿´Çï¿ô¤¬Áý¤¨±¿Æ°µ¡Ç½¤ÎÄã²¼ ÍÏ·ì¤Ë¤è¤ëÉÏ·ì¡£¤¤¤¯¤Ä¤«¤ÎÍýͳ¤ÇÀÖ·ìµå¤¬Ç˲õ¤µ¤ì¤ë¤³¤È¤òÍÏ·ì¤È¸À¤¦¡£Ç˲õ¤µ¤ì»½ý¤ò¼õ¤±¤¿ÀÖ·ìµå¤Ïç£Â¡¡¦´Î¡¤ª¤è¤Ó¹ü¿ñ¤Ë¤ª¤±¤ëÌȱַϤˤè¤Ã¤Æ·ì±Õ¤«¤é½üµî¤µ¤ì¤ë¡£ÀÖ·ìµå¤Ï»ÀÁǤò±¿¤ÖƯ¤­¤ò»ý¤Ä¤Î¤ÇÁ´¿È¤Î³Æµ¡Ç½¤ÎÄã²¼¤Ø¤È¿Ê¤à¡£Í½¸åÉÔÎÉ¡£
4ºÐ¤«¤é5ºÐ¤Îȯ¾É¤¬Â¿¤¯¥á¥¹¸¤¤Ï¥ª¥¹¸¤¤Î4Çܤۤɥꥹ¥¯¤¬¹â¤¤¡£
°Ê²¼ÍÏ·ìÉÏ·ì¤Ç¤ÏÁóÇò¤ä²«áÕ¤âÂåɽŪ¤Ê¾É¾õ¤À¤¬¸¤¤Ç¤Ï¤ï¤«¤ê¤Ë¤¯¤¤(»õ·Ô¤äÇòÌܤÇȽÃǤǤ­¤ë¤Î¤À¤¬)¡£¥Ü¥¹¥È¥ó¥Æ¥ê¥¢¤Ç¤ÏAR
¾ïÀ÷¿§ÂÎÀ­¡¢Ã±°ì°äÅÁ»Ò ¥×¡¼¥É¥ë¡¢¥Ó¡¼¥°¥ë¡¢¥Ü¥¹¥Æ¥ê¡¢¥é¥Ö¾¿
273 Haemolytic anaemia, autoimmune
¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
ÍÏ·ì¤Ë¤è¤ëÉÏ·ì ¼«¸Ê¹³ÂΤˤè¤Ã¤Æ¼«Ê¬¤ÎÀÖ·ìµå¤òÄ̾ï¤è¤êÁ᤯Ç˲õ¤·ÍÏ·ì¤òµ¯¤³¤¹¡£Í½¸åÉÔÎÉ unknown ¿
274 Haemolytic anaemia, nonspherocytic
Èóµå¾õÀ­¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
* *
°äÅÁÀ­ÍÏ·ìÀ­ÉÏ·ì¾ÉÎã¤ÎËö¾¿·ìÀÖ·ìµå¤ò´Ñ»¡¤¹¤ë¤È,ŵ·¿Åª¤Ê¾®·¿µå¾õÀÖ·ìµå¾É¤òÄ褹¤ë·²¤È,¤³¤ì¤òǧ¤á¤Ê¤¤·²¤È¤¬¤¢¤ë.Á°¼Ô¤ò°äÅÁÀ­µå¾õÀÖ·ìµå¾É,¸å¼Ô¤òÈóµå¾õÀÖ·ìµåÀ­ÍÏ·ìÀ­ÉÏ·ì¤È¤¤¤¦.¤³¤Î¸å¼Ô¤Îɰø¤Ï¼ï¡¹¤Ç¤Ï¤¢¤ë¤¬,ÂçÊ̤·¤Æ, 1)Ëì°Û¾ï¾É, 2)¥Ø¥â¥°¥í¥Ó¥ó°Û¾ï¾É, 3)²òÅü·Ï¹ÚÁǰ۾ï¾É¤¬ÃΤé¤ì¤Æ¤¤¤ë. 1)¤È¤·¤Æ¤Ï,Í­¸ýÀÖ·ìµå¾É,Í­ÛùÀÖ·ìµå¾É,ÂʱßÀÖ·ìµå¾É, 2)¤È¤·¤Æ¤Ï¥µ¥é¥»¥ß¥¢,¼ï¡¹¤Î°Û¾ï¥Ø¥â¥°¥í¥Ó¥ó¾É, 3)¤Ç¤Ï¥Ô¥ë¥Ó¥ó»À¥­¥Ê¡¼¥¼·ç˳¾É¤Ê¤É¤¬³ºÅö¤¹¤ë.¢ª°äÅÁÀ­ÂʱßÀÖ·ìµå¾É
¾ïÀ÷¿§ÂÎÀ­¡¢unknown ¥Ó¡¼¥°¥ë
275 Haemolytic anaemia, primary autoimmune
¸¶È¯À­¼«¸ÊÌȱÖÀ­ÍÏ·ìÀ­ÉÏ·ì
Çö¤¤Ç´Ëì¤ÎÊø²õ(Ç´Ëì¤ÎÇö¤¤²Õ½ê¤«¤é¤Î½Ð·ì)¡¢¸µµ¤¾ÃÄÀ¡¢¿²¤Æ¤Ð¤«¤ê ¸¶È¯À­¤È¤Ï¾¤Îɵ¤¤Î·ë²Ì¤È¤·¤Æµ¯¤³¤ëɵ¤¤Ç¤Ï¤Ê¤¯¡¢¤½¤Îɵ¤¼«ÂΤ¬¸¶°ø¤È¤Ê¤ë¤â¤Î¤ò»Ø¤¹¤Î¤Ç¡¢¼«¸ÊÌȱ֤ÎÉÔ¶ñ¹ç¤¬¸¶°ø¤È¤Ê¤Ã¤ÆÍÏ·ìÀ­ÉÏ·ì¤òµ¯¤³¤¹Éµ¤
¥¹¥Æ¥í¥¤¥É·Ï¹³±ê¾ÉÌô¤Î1¤Ä¤Ç¤¢¤ë¥×¥ì¥É¥Ë¥¾¥í¥ó¤Ç·Ú²÷¤¹¤ë¤è¤¦¤À
¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
276 Haemolytic uremic syndrome
ÍÏ·ìÀ­Ç¢ÆÇ¾É¾É¸õ·²
Ê¢ÄË¡¢·ìÀ­²¼Î¡ÊØ¡¢ÍÏ·ì¤Ë¤è¤ëÉϷ졣ǢÆÇ¾É(BUN¹âÃÍ)¤Ë¤è¤ë°Õ¼±¾ã³² Èù¾®·ì´ÉÀ­ÍÏ·ìÀ­ÉÏ·ì¡¢µÞÀ­¿ÕÉÔÁ´¤ª¤è¤Ó·ì¾®Èĸº¾¯¾É¤òÆÃħ¤È¤¹¤ëÉÂÂÖ¡£Ê¬ÊÚ¸å¿ÕÉÔÁ´¤ä°­À­¹â·ì°µ¤Ë¹çÊ»¤¹¤ë¤³¤È¤â¤¢¤ë¡£ ¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
277 Haemophagocytic syndrome
·ìµåìÅ¿©¾É¸õ·²
* hemophagocytic syndrome ³èÀ­²½¥Þ¥¯¥í¥Õ¥¡¡¼¥¸¤Ë¤è¤ë·ìµåìÅ¿©À­¼À´µ
¿ÇÃǤϹü¿ñÀü»É¤ÎºÙ˦¿Ç¤Î¤è¤¦¤À
¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
278 Haemophilia A
·ìͧÉÂA
¥ï¥¯¥Á¥óÀܼï¤Ê¤ÉÃí¼Í¸å¤Î¼ð¤ì¡¦¤·¤³¤ê¡¢½Ð·ì»þ´Ö¤Î±äĹ¡¢Ç˹ԡ¢´ØÀá±ê Genes:F8
ÂèVIII°ø»Ò·ç˳¤Ë¤è¤ë½Ð·ìÀ­¼À´µ¡£¿·À¸»ù¤ÎçÁÂӽзì²á¿¡¢ÃÇÈø¡¦¼ª¡¢ÏµÄÞÀÚ½ü»þ¡¢»õ¤ÎÀ¸¤¨ÊѤï¤ê»þ¤Î½Ð·ìÎÌÁýÂç¡¢ÄÞÀÚ¤ê»þ¤Î½Ð·ì¤Ê¤É½Å¾ÉÅ٤ˤϸÄÂκ¹¤¬·ã¤·¤¤¤¬¤Á¤ç¤Ã¤È¤·¤¿¤³¤È¤Ç¤è¤¯·ì¤¬½Ð¤ë¡£Æü¾ï¤ÎÀµ¾ï¤Êư¤­¤Ç´ØÀá¤Ë·Ñ³Ū¤Ê½Ð·ì¤¬µ¯¤³¤ê(ɪ¤äɨ¤Ê¤É)´ØÀá±ê¤Ø¤È°Ü¹Ô¤¹¤ë¡£XÀ÷¿§ÂÎÏ¢º¿ÎôÀ­°äÅÁ¤Ê¤Î¤ÇÄ̾ï¤Ï¥ª¥¹¤ËȯÀ¸¤·¥á¥¹¤Ï¥­¥ã¥ê¥¢¡¼¤À¤¬¤Þ¤ì¤Ëȯ¾É¥á¥¹¤¬¤¤¤ë
XR ¿
279 Haemophilia B
·ìͧÉÂB
·ìͧÉÂA¤È¤Û¤ÜƱ¤¸¤â¤Î¤Î¤Û¤«¡¢½Ð·ìÀ­¤Î²¼Î¡¡¢¿©ÍßÉÔ¿¶¡¢Ìµµ¤ÎÏ Genes:F9
ÂèIX°ø»Ò·ç˳¤Ë¤è¤ë½Ð·ìÀ­¼À´µ¡¢¥¯¥ê¥¹¥Þ¥¹É¡¢¥È¥í¥ó¥Ü¥×¥é¥¹¥Á¥ó¥³¥ó¥Ý¡¼¥Í¥ó¥È¡ÊPTC¡Ë·ç˳¾É¡£ÂΤΥµ¥¤¥º¤¬¾®·¿¡¦Á餻·¿¤Ë¤Ê¤ë¤Û¤ÉÇ˹Ԥ¬ÆÍÁ³¸½¤ì¤ë·¹¸þ¤¬¸«¤é¤ì¤ë
XR ¿
315 Hyperbilirubinaemia, unclassified
*̤ʬÎà¤Î¹â¥Ó¥ê¥ë¥Ó¥ó·ì¾É
²«áÕ¡¢¸µµ¤¾ÃÄÀ¡¢¿©ÍßÄã²¼¡¢ ¿·À¸»ù»àË´¤¬¤¢¤ë¤¬¸¤¤Ç¤Ï²«áÕ¤¬¤ï¤«¤ê¤Ë¤¯¤¤¤¿¤á¸«²á¤´¤µ¤ì¤ë¥±¡¼¥¹¤¬Â¿¤¤¤È»×¤ï¤ì¤ë unknown *
318 Hypereosinophilic syndrome
¹¥»ÀµåÁý²Ã(¿)¾É¸õ·²
Á´¿È¤Îȯ¿¾¤äáڤߡ¢ÉÏ·ì¡¢²¼Î¡¡¢Ê¢ÉôáÛÚ»¡¢ÂνŸº¾¯¡¢±Ê³Ū¤Ê³± Èé²¼¤Î¤·¤³¤ê¡¢¾Ã²½´É¡¢¹ü¿ñ¡¢ç£Â¡¡¢¥ê¥ó¥ÑÀá¡¢ÇÙ¤ä´Î¡¤Ê¤É¤Î¡´ï¤ò¼è¤ê°Ï¤àÁÈ¿¥¤ÎÈî¸ü¡¢¸ÆµÛº¤Æñ¡¢¶»¿å¡¦ÉÔÀ°Ì®¡¦ÁÎ˹Êۤ仰ÀíÊÛµÕή¤ò´Þ¤à¿´Â¡¥È¥é¥Ö¥ë¡¢³Æ¼ï¡´ïÉÔÁ´¤Ê¤É¤â¾É¾õ¤ÎÎ㤬¤¢¤ë¡£Ëö¾¿·ìÃæ¤Î¹¥»Àµå¤¬°Û¾ï¤Ë¿¤¤¾õÂ֤ǡ¢´óÀ¸Ãî´¶À÷¤ä¥¢¥ì¥ë¥®¡¼È¿±þ¡¢¥¢¥È¥Ô¡¼À­¼À´µ¤Çµ¯¤³¤ë¤³¤È¤â¤¢¤ë(¹¥»Àµå¤ò¸º¤é¤¹°ø»Ò¤Î¤Ò¤È¤Ä¤Ë¤Ï¥¹¥È¥ì¥¹¤¬¤¢¤ë)¡£Áý²Ã¾õÂÖ¤¬Ä¹°ú¤¯¤ÈÆÃȯÀ­¹¥»ÀµåÁý²Ã¾É¸õ·²¤È¿Ê¤ß¿´Â¡¡¢ÇÙ¡¢ç£Â¡¡¢¤ª¤è¤Ó¿À·Ð·Ï¤Ê¤É¤¢¤é¤æ¤ë¡´ï¤¬¿¯¤µ¤ìͽ¸åÉÔÎÉ unknown *
319 Hypergammaglobulinaemia
¹â¥¬¥ó¥Þ¥°¥í¥Ö¥ê¥ó·ì¾É
* ËýÀ­³èưÀ­´Î¼À´µ¡¢¼«¸ÊÌȱÖÀ­´Î±ê
¦Ã¥°¥í¥Ö¥ê¥ó¤È¤ÏÌȱ֤˴ØÍ¿¤¹¤ë·ì±ÕÃæ¤Ë¤¢¤ë¤¿¤ó¤Ñ¤¯¼Á
¤³¤ì¤¬¤¢¤Ã¤ÆËýÀ­ÂñÕÁ£±ê¤È´¥ÁçÀ­³Ñ·ëËì±ê(¤¬¼çÄ¥)¤Ê¤Î¤Ï¥·¥§¡¼¥°¥ì¥ó¾É¸õ·²(¼«¸ÊÌȱּÀ´µ)
unknown G¥·¥§¥Ñ
320 Hyperhomocysteinemia
¹â¥Û¥â¥·¥¹¥Æ¥¤¥ó·ì¾É
ËýÀ­°ßIJ¼À´µ¡¢ÉÏ·ì¡¢¿´·ì´É¼À´µ¡¢·ìÀò¾É¡¢Äã·ì°µ¾É ¥Ò¥È¤Î¥±¡¼¥¹Æ±ÍͤËÍÕ»À¤È¥Ó¥¿¥ß¥óB6¤äB12¤ÎÄã²¼¤¬¸«¤é¤ì¤ë¡£Ä㥳¥Ð¥é¥ß¥ó·ì¾É¡£¥°¥ì¥¤¥Ï¥¦¥ó¥É¤Ç¤ÏÉÑÈˤ˵¯¤³¤Ã¤Æ¤¤¤ë unknown¡Ê¤ª¤½¤é¤¯Â¿°ø»Ò G¥Ï¥¦¥ó¥É
381 Leukemia, chronic monocytic
ËýÀ­Ã±µåÀ­Çò·ìÉÂ
Î×¾²¾É¾õ¤Î¤Ê¤¤Çò·ìµåÁý²Ã¾É Genes: BCR
¥Ò¥È¤Î¥Õ¥£¥é¥Ç¥ë¥Õ¥£¥¢À÷¿§Âΰ۾ï¤È¤Û¤ÜƱ¤¸
¾ïÀ÷¿§ÂÎÀ­¡¢Ã±°ì *
382 Leukocyte adhesion deficiency, type I
Çò·ìµåÇ´ÃåÉÔÁ´¾É­µ·¿
À¸¸å12½µ°ÊÁ°¤«¤éÀÜÃåʬ»Ò·ç»¤Ë¤è¤ë°×´¶À÷À­¡¢ÄãÂνš¢È¯Ç®¡¢¿©ÍßÉÔ¿¶¡¢»õÆù±ê¡¢Î®Þ·¡¢½ÅÅÙ¤ÎÈéÉæ´¶À÷¡£Áá´ü»àË´(¿¤¯¤Ï6¥ö·îÎð) Genes:ITGB2
Çò·ìµåɽÌ̾å¤ÎÇ´Ãåʬ»Ò¤Î·ç»¤ò¸¶°ø¤È¤¹¤ëÇò·ìµåµ¡Ç½°Û¾ï¾É¡£Çò·ìµå¿ô¤ÎÁý²Ã¡¢¹¥Ãæµå¤Îº¸Êý°Üư
Optigen¤ÇI¥»¥Ã¥¿¡¼RW¥»¥Ã¥¿¡¼°äÅÁ»Ò¸¡ºº¤¢¤ê
AR I¥»¥Ã¥¿¡¼¡¢IRW¥»¥Ã¥¿¡¼
383 Leukocyte adhesion deficiency, type III
Çò·ìµåÇ´ÃåÉÔÁ´¾É­··¿
½ý¤Î¼£¤ê¤ÎÃ٤졢ǴËì½Ð·ì¤ÎÁý²Ã¡¢ìì¹Ô¡¢»õ¼þÉ¡¢È¯Ç®¡¢°×´¶À÷À­¡¢Çò·ìµåÁý²Ã Gene: FERMT3
Çò·ìµåÀÜÃå·ç»¾É¤Ï¡¢ÌȱÖÉÔÁ´¤Ë¤è¤êÆÃħÉÕ¤±¤é¤ì¤ë°äÅÁÀ­¼À´µ¡£2014ǯ¥á¥ë¥Ü¥ë¥ó½Ã°åÀìÌ祻¥ó¥¿¡¼¤Ç16¥ö·î¥ª¥¹G¥·¥§¥Ñ¡ß¥í¥Ã¥È¤ÎF1»¨¼ï¤¬È¯¾É¤·¤¿¸¦µæ¡£G¥·¥§¥Ñ¤Ë¤Ï°ÊÁ°¤«¤éÊó¹ð¤¬¤¢¤Ã¤¿¤¬»¨¼ï¤Ï½é¤á¤Æ¤È¤¤¤¦ÏÃ
AR G¥·¥§¥Ñ
392 Lymphoedema
¥ê¥ó¥ÑÉâ¼ð
»Í»è¤Î¤à¤¯¤ß¡¢½ÅÅ٤ǤÏÈéÉæ¤ÎÊÑ·Á¤ä¹Å²½(¾ÝÈé¾É) ¥ê¥ó¥Ñ´É·Ï¤ÎÄã·ÁÀ®¤«·ì´É±¿Æ°¿À·Ð¤Î°Û¾ï¡£¥ê¥ó¥Ñ´É¤¬¾¯¤Ê¤«¤Ã¤¿¤êƯ¤­¤¬¤è¤¯¤Ê¤¤¤Ê¤É¤Çή¤ì¤ë¤Ù¤­¥ê¥ó¥Ñ±Õ¤ò½èÍý¤Ç¤­¤Ê¤¤¾õÂÖ¡£
À¸¤Þ¤ì¤Ä¤­¤ÎÀèÅ·À­¤È¸¶°øÉÔÌÀ¤Î¸åÅ·À­(³°²Ê¼ê½Ñ¤Ë¤è¤ëÆó¼¡À­¤ä´¶À÷¾É¡¦°­À­¼ðáç¤Ê¤É¤ò½ü¤¯)¤â´Þ¤Þ¤ì¤ë¤³¤È¤¬¤¢¤ë¡£
¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
395 Lymphoproliferative disease
¥ê¥ó¥ÑµåÁý¿£¾É
¥ê¥ó¥ÑÀá±ê¡¢¥ê¥ó¥ÑÉâ¼ð¡¢¥ê¥ó¥Ñ¼ð¡¢¶Ý¾õ©Æù¼ð ¥ê¥ó¥Ñ(¥ê¥ó¥Ñ±Õ)¤ÏÁÈ¿¥¤«¤éÁÈ¿¥±Õ(Ï·ÇÑʪ)¤ò¼è¤ê½ü¤¯Ìò³ä¡¢µÛ¼ý¤µ¤ì¤¿»éËûÀ¤È»é¼Á¤òÆýäö¤È¤·¤Æ½Û´Ä·Ï¤Þ¤Ç±¿¤ÖÌò³ä¡¢Ã±µå¤ä¹³ÂλºÀ¸ºÙ˦¤Ê¤É¤Î¥ê¥ó¥Ñµå¤ò¤Ï¤¸¤á¤È¤¹¤ëÌȱֺÙ˦¤ò»ºÀ¸¤¹¤ë3¤Ä¤ÎÌò³ä¤¬¤¢¤ë¡£Ï·ÇÑʪ¤Î²ó¼ý¤Ë¥È¥é¥Ö¥ë¤¬µ¯¤³¤ë¤ÈÁÈ¿¥Ãæ¤Ë;ʬ¤Ê¤â¤Î¤¬Î¯¤Þ¤Ã¤Æ¥ê¥ó¥Ñ¤¬Áý¤¨¤ë ¿°ø»Ò *
402 May-Hegglin anomaly
¥á¥¤¥Ø¥°¥ê¥ó°Û¾ï
̵¾É¾õ¡Á·ÚÅ٤νзì¾É¾õ Gene: MYH9
µðÂç·ì¾®ÈÄ¡¢·ì¾®Èĸº¾¯¡¢Çò·ìµåÉõÆþÂΤ¬ÆÃħ
AD¤« ¥Ñ¥°
404 Megakaryoblastic leukaemia
µð³Ë²êµåÇò·ìÉÂ
¿ô¥ö·î¤ËÅϤë¿Ê¹ÔÀ­¤Î¶ÚÎÏÄã²¼¤ÈÂνŸº¾¯¡£Ìµµ¤ÎÏ¡¢¿©ÍßÉÔ¿¶¡¢ÓÒÅÇ¡¢²¼Î¡¤ª¤è¤Ó±Ê³Ū¤ÊȯǮ¡¢Â¿°û¡¦Â¿Ç¢ ȯ¾É¤¹¤ë¤ÈÄ̾ï·ò¹¯Åª¤Ê¥Ô¥ó¥¯¿§¤ÎÇ´Ë줬ÀÖ·ìµåÉÔ­¤Î¤¿¤á¿§¤¬Çö¤Þ¤ë¡£½Å¾É²½¤ÏÇòÌܤ¬¿¿¤ÃÀ֤˽¼·ì¡¢°×´¶À÷À­¡¢Â¿Â¡´ïÉÔÁ´ ¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
498 Neutropenia, cyclic
¼þ´üÀ­¹¥Ãæµå¸º¾¯¾É
¼þ´üŪ(Ê¿¶Ñ10¡Á12Æü¥µ¥¤¥¯¥ë)¤ÊºÆÈ¯À­È¯Ç®¡¢¿©ÍßÉÔ¿¶¡¢¸«Åö¼±¾ã³²¡¢¿¶Àï¡¢·ÚÅ٤β¼Î¡¡¢Æâ½Ð·ì(¤¢¤¶)¡¢°×´¶À÷À­ Genes: AP3B1
ÊÌ̾¥°¥ì¡¼¥³¥ê¡¼¾É¸õ·²¡£Çò·ìµå¤Î¶Ëü¤Ê¸º¾¯¤Ë¤è¤ê´¶À÷¾É¤Ë¤è¤Ã¤ÆÁá´ü»àË´¡£¥°¥ì¡¼(¸¤¤ÎÌÓ¿§¤Î¸Æ¤ÓÊý¤È¤·¤Æ¤Ï¥Ö¥ë¡¼)¤Î¥é¥Õ¥³¥ê¡¼¡¢¥¹¥à¡¼¥¹¥³¥ê¡¼¡¢¥Ü¡¼¥À¡¼¥³¥ê¡¼¡¢¥¢¥á¥ê¥«¥ó¥³¥Ã¥«¡¼¥¹¥Ñ¥Ë¥¨¥ë¡¢¥Ý¥á¥é¥Ë¥¢¥ó¤Ëµ¯¤­¤ë¤È¸À¤ï¤ì¤ë¤¬¡¢¥Ö¥ë¡¼¤òȯ¸½¤¹¤ë¥À¥¤¥ê¥å¡¼¥·¥ç¥ó°ø»ÒÎôÀ­¥Û¥âdd¤Î¸¤¤ÎÂç¿¿ô¤Ï¤³¤Î¼À´µ¤È¤Ï̵±ï¤Ê¤Î¤Ç¡¢dË¿¤È¤¤¤¦°ø»Ò¤¬¸¶°ø¤Ç¤¢¤ë¤Î¤«¤Þ¤¿¤Ï¤³¤Î¼À´µ¤Î°ø»Ò¤¬¹õ¤¤¿§ÁǤòÂà¿§¤µ¤»¤ë¤Î¤«¤ÏÉÔÌÀ
AR ¥³¥ê¡¼
516 Osmotic resistance of erythrocytes
ÀÖ·ìµå¿»Æ©°µÄñ¹³
ËýÀ­Åª¤ÊÉϷ졦æ¿å¡¢ºÆÈ¯¤¹¤ë²«áÕ ÀÖ·ìµå¿»Æ©°µÄñ¹³¸¡ºº¤È¤ÏÀÖ·ìµå¤ÎʪÍýŪ¤Ê³°ÎϤˤè¤êÊø²õ¡ÊÍÏ·ì¡Ë¤¹¤ë¤¬¡¢¤³¤ì¤ËÂй³¤¹¤ëǽÎϤò¤ß¤ë¸¡ºº¡£ÍÏ·ìÀ­ÉÏ·ì¤Ê¤É¤Ç¼å¤¯¤Ê¤ë¡£1964ǯ¤Ë¥Õ¥©¥Ã¥¯¥¹(Dr.Michael W.Fox??)¤¬¸¦µæ¤·¤Æ¤¤¤¿ÌÏÍÍ ¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
543 Pelger-Huet anomaly
¥Ú¥ë¥²¥ë¡¦¥Õ¥¨¥Ã¥È³Ë°Û¾ï
ɵ¤¤Ç¤Ï¤Ê¤¤ Ìȱֵ¡Ç½¤¬Â»¤Ê¤ï¤ì¤Ê¤¤ÈϰϤǹ¥Ãæµå¤È¹¥»Àµå¤¬³Ë°Û¾ï¤ò¤­¤¿¤¹(AD¤â¤¢¤ë) ¾ïÀ÷¿§ÂÎÀ­¡¢unknown *
555 Platelet delta-storage pool disease
*·ì¾®Èĥǥ륿Ãù¢¥×¡¼¥ëÉÂ
* ***storage pool deficiency ¤Ï¾®»ùËýÀ­·ì¾®ÈļÀ´µ
·ì¾®Èĵ¡Ç½Äã²¼¤Ë¤è¤ë½Ð·ì·¹¸þ¤È´ã¤äÈéÉæ¤Î¿§ÁÇæ¼º¤È¹ü¿ñ¤Ø¤Î¿§ÁÇÄÀÃ夬¼ç¾É¾õ¤Î¥Ø¥ë¥Þ¥ó¥¹¥­¡¼-¥×¥É¥é¥Ã¥¯Hermanskt-Pudlak¾É¸õ·²(¥¢¥ë¥Ó¥Î¤Î°ì·²)¤Î¡¢Çò²½¥Ê¥·¤¬1979ǯ¥×¥¨¥ë¥È¥ê¥³¿Í¤Ë¸«¤é¤ì¤¿
¾ïÀ÷¿§ÂÎÀ­¡¢unknown ϵí¤Ç¤è¤¯¸¦µæ¤µ¤ì¤Æ¤¤¤ë
562 Polycythemia
ÀÖ·ìµåÁý²Ã¾É
ÈéÉæ¤ÎÀ֤ߡ¢Á´¿È¤Î¤«¤æ¤ß¡¢Ç´Ëì¤Î½¼·ì(¥Ò¥È¤Ç¤ÏƬÄˤ伪ÌĤê¤Ê¤É¤â)¡¢¾É¾õ¤¬¿Ê¤à¤È·ì´É¤¬µÍ¤Þ¤ê¤ä¤¹¤¯¤Ê¤ë¡¦Äã»ÀÁǾõÂÖ¤Ê¤É Genes: JAK2
̵µ¤ÎϤˤʤ俤걿ư¤ò¤·¤¿¤¬¤é¤Ê¤«¤Ã¤¿¤ê¿°û¿Ǣ¾É¾õ¤ä¤±¤¤¤ì¤óȯºî¤â¤¢¤ë
AD,AR ¥ì¥ª¥ó
578 Prekallikrein deficiency
¥×¥ì¥«¥ê¥¯¥ì¥¤¥ó·ç˳¾É
»ß·ì¤¬ÃÙ¤¤¡¢Æâ½Ð·ì¡¢Àֳ쿧Ǣ¡¢¥¿¡¼¥ëÊØ Genes: KLKB1
Æâ½Ð·ì¤Î¤Û¤«²¼Î¡¤äÂνŸº¾¯¤Ê¤É½Ð·ìÀ­¼À´µ¤Îŵ·¿Åª¤Ê¾É¾õ¤Ï½Ð¤ë¤¬½Ð·ì¾É¾õ¤¬¤¢¤Þ¤ê¤Ò¤É¤¯¤Ê¤¤·ì±Õ¼À´µ¡£APTT±äĹ(·ì¤¬¸Ç¤Þ¤ë»þ´Ö¤òÄ´¤Ù¤ë¸¡ºº)¤¬ÃøÌÀ¡£»³¸ýÂç³ØÇÀ³ØÉô½Ã°å³Ø²Ê¤Ç¸¦µæ¤¢¤ê¡£¥Õ¥ì¥Ã¥Á¥ã¡¼°ø»Ò·ç˳¾É¤È¹çÊ»¤â
AR C¥·¥ã¡¼¥Ú¥¤
627 Scott Syndrome
¥¹¥³¥Ã¥È¾É¸õ·²
·ì±Õ¶Å¸Ç¾ã³² Gene: ANO6
AR G¥·¥§¥Ñ
629 Selective ADP deficiency
*ÆÃÄêADP·ç˳
*·ì±Õ¶Å¸Ç¾ã³²??? ¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¤È·ì¾®ÈÄ¿ô¤ÏÀµ¾ï¤Ç¤â½Ð·ì»þ´Ö¤¬±äŤµ¤ì¤ë???
ADP¤Ï¥¢¥Ç¥Î¥·¥óÆó¥ê¥ó»ÀAdenosine diphosphate¤Îά¤Ç¥¢¥Ç¥Ë¥ó¡¢¥ê¥Ü¡¼¥¹¡¢2¥ê¥ó»Àʬ»Ò¤Ç¹½À®¤µ¤ì¡¢¥¢¥Ç¥Î¥·¥ó»°¥ê¥ó»À¤«¤é1¸Ä¤Î¥ê¥ó»À¤¬¼º¤ï¤ì¤ëÂå¤ï¤ê¤Ë¹â¥¨¥Í¥ë¥®¡¼¤È¥¢¥Ç¥Î¥·¥óÆó¥ê¥ó»À¤ËÊ̤ì¤ë¡£¥¨¥Í¥ë¥®¡¼¤¬Í¿¤¨¤é¤ì¤ë¤È¡¢ºÆ¤ÓÎÕ»À¤È·ë¹ç¤·¡¢¥¢¥Ç¥Î¥·¥ó»°¥ê¥ó»À¤Ø¤ÈÊѲ½¤¹¤ëÂÎÆâʪ¼Á¤Î¤Ò¤È¤Ä¡£
AD *
639 Spherocytosis
µå¾õÀÖ·ìµå¾É
·ì±Õ¸¡ºº¤ÇÀÖ·ìµåÃͤËÂ礭¤Ê°Û¾ï¤¬¸«¤é¤ì¤Ê¤¤ÍÏ·ìÀ­ÉϷ졢磼𡢲«áÕ¡¢ÃÀÀС¢È¯Ã£ÃÙ±ä ÍÏ·ìÀ­ÉÏ·ì¤Î°ì¼ï¤Çʸ»úÄ̤êÀÖ·ìµå¤¬µå·Á¤Ë¤Ê¤Ã¤Æ¤¤¤ë¡£µå¾õ¤ÎÀÖ·ìµå¤ÏʪÍýŪ¤Ëç£Â¡¤òÄ̲á¤Ç¤­¤ºÇ˲õ¤µ¤ì¤ë¡£(Wiki) AD *
655 Stomatocytosis
¸ý(¿°)¾õÀÖ·ìµå¾É¡¢Í­¸ýÀÖ·ìµå¾É
¸åÅ·À­¤ÎÍÏ·ìÀ­ÉÏ·ì¡¢·ìÇ¢(·ìÇ¢¤ÏÄ«¤¬Â¿¤¤) ÀèÅ·À­¤ÎÀÖ·ìµå°Û¾ï¾É¡£ÀÖ·ìµå¤ÏÄ̾￿¤óÃæ¤¬¤¯¤Ü¤ó¤À±ßÈ×·¿¤À¤¬¤³¤Îɵ¤¤Ç¤Ï¤¯¤Ü¤ß¤ÎÉôʬ¤¬Âʱ߷¿¤Ç¸ý¤ò¹­¤²¤¿¤è¤¦¤Ë¸«¤¨¤ë unknown *
671 Thrombasthenia
·ì¾®ÈÄ̵ÎϾÉ
¤Û¤È¤ó¤É¤Î·ì¾®ÈĤΥȥé¥Ö¥ë¤Ï¥á¥¹¤Îȯ¾ð½Ð·ì¤Î½Ð·ìÎ̤ȴü´Ö¤ò¿¤¯¤¹¤ë
½Ð·ì»þ´Ö¤Î±äĹ¡¢¸¤¤Ç¤Ïµ©¤ÊÉ¡·ì¤Ê¤É¤â¤è¤¯¸«¤é¤ì¤ë
Genes: ITGA2B
·ì¾®ÈĤˤè¤ë°ì¼¡»ß·ì¤¬ÃÙ¤ì¤Æ½Ð·ì»þ´Ö¤¬±äŤ¹¤ë¡£½Ð·ìÍͼ°¤ÏÈéÉæÇ´Ëì½Ð·ì¤¬Ãæ¿´¡£Î±¼éÃæ¤ä½¢¿²Ãæ¤Î½Ð·ì¤Ëµ¤¤Å¤¯¤Î¤¬ÃÙ¤ì¤ë¤ÈÂçÎ̽зì¤È¤Ê¤ë¾ì¹ç¤â¤¢¤ë¡£
¾ïÀ÷¿§ÂÎÀ­ *
672 Thrombocytopaenia
·ì¾®Èĸº¾¯¾É
·ì¾®ÈĤ¬¾¯¤Ê¤¯¤Ê¤ë¤³¤È¤Ë¤è¤Ã¤Æµ¯¤­¤ëÈé²¼½Ð·ì¤ä»ß·ì°Û¾ï Genes: TUBB
·ì¾®ÈĤˤè¤ë°ì¼¡»ß·ì¤¬ÃÙ¤ì¤Æ½Ð·ì»þ´Ö¤¬±äŤ¹¤ë¡£½Ð·ìÍͼ°¤ÏÈéÉæÇ´Ëì½Ð·ì¤¬Ãæ¿´
AR ¥­¥ã¥Ð¥ê¥¢
673 Thrombocytopathy
·ì¾®ÈľÉ
Äˤߤ䤷¤Ó¤ì¡¢¤á¤Þ¤¤¤äƬÄˤǸµµ¤¾ÃÄÀ ·ì¾®ÈĤ¬°Û¾ï¤ËÁý¤¨¤ë¤³¤È¤Ë¤è¤Ã¤Æ·ìÀò¤¬¤Ç¤­¤ä¤¹¤¯¤Ê¤ë(Áý¤¨¤ë¸¶°ø¤Ï¿¤¯¤¬Â¤·ì´´ºÙ˦¤Î°Û¾ïÁý¿£)
¥Þ¥¦¥¹¤Ç¤ª¤³¤Ê¤ï¤ì¤¿¼Â¸³¤Ç¡¢´Î¡¤ÎȾʬ¤Û¤ÉÀÚ½ü¤·¤¿¥Þ¥¦¥¹¤Ë·ì¾®ÈÄÍ¢·ì¤ÇÊ¿¾ï¤ÎÇܤۤɤËÁý¤ä¤¹¤È´Î¡¤ÎºÆÀ¸¤¬Â¥¿Ê¤µ¤ì¤¿¡£
unknown *
674 Thrombocytopenic purpura, autoimmune
¼«¸ÊÌȱÖÀ­·ì¾®Èĸº¾¯À­»çÈÃÉÂ
ÅÀ¾õ½Ð·ì¡¦»çÈᣲ¼·ì¤ä·ìÇ¢¡¢»õ·Ô¤äÉ¡¡¦Æ¬³¸Æâ½Ð·ì¤â¤¢¤ë¡£ ³°²Ê¼ê½Ñ¤Î¸å¤ËÈé²¼½Ð·ì¤¬µ¯¤­¤Æ¾Ü¤·¤¯¸¡ºº¤¹¤ë¤Èȯ³Ð¤¹¤ë¤³¤È¤¬¤¢¤ë¤¬¡¢Ä̾ï¤ÏÀÖ·ìµå¤äÇò·ìµå¤Ë°Û¾ï¤¬¸«¤é¤ì¤Ê¤¤°Ù¡Ö·Ú¤¯¤Ö¤Ä¤±¤¿¤À¤±¡×¤Ê¤É¤È¤¤¤¦¿ÇÃǤ¬Â¿¤¤¤È¹Í¤¨¤é¤ì¤ë¡£
»²¾È;¥Ò¥È¤ÎÆÃȯÀ­·ì¾®Èĸº¾¯À­»çÈÃÉÂ
unknown *
675 Thrombopathia
*·ì¾®Èĸº¾¯
·ì¾®ÈĤ¬¸º¾¯¤¹¤ë¤³¤È¤½¤Î¤â¤Î Genes: RASGRP1
·ì±Õ¶Å¸Ç¾ã³²
AR ¥Ð¥»¥Ã¥È¡¢¥¹¥Ô¥Ã¥Ä
676 Thromboxane responsiveness of platelets
*¥È¥í¥ó¥Ü¥­¥µ¥óÈ¿±þÀ­·ì¾®ÈÄ
* *¥È¥í¥ó¥Ü¥­¥µ¥ó¤Ï·ì¾®ÈĤÇ¿¤¯»ºÀ¸¤µ¤ì·ì¾®ÈĤζŽ¸¤ä·ì´ÉÊɤμý½Ì¤ò°ú¤­µ¯¤³¤¹¥ª¥­¥µ¥ó´Ä¤òÍ­¤¹¤ëÀ¸Íý³èÀ­Êª¼Á¤Î°ì·²¡¢TX¡£ AR *
679 Trapped Neutrophil Syndrome
Ê᪹¥Ãæµå¾É¸õ·²
¶Ëü¤ÊÀ®Ä¹Ãٱ䡢³Ø½¬¾ã³²(Àº¿ÀÃÙÂÚ)¡¢¾Ã²½´É¾ã³²¡¢°×´¶À÷¡¢Ç˹ԡ¢½Û´Ä·ì±ÕÆâ¤Î¹¥Ãæµå¤¬¸º¾¯(¹ü¿ñ¤Çºî¤é¤ì¤Æ¤Ï¤¤¤ë) Genes: VPS13B
¹¥Ãæµå¸º¾¯¡¦ºÆÈ¯À­´¶À÷¾É¡¦¥Ò¥È¤Îmyelokathexis(¥ß¥¨¥í¥«¥»¥­¥·¥¹¾É¸õ·²)¤È¥¤¥Ü¡¦Ä㥬¥ó¥Þ¥°¥í¥Ö¥ê¥ó·ì¾É¡¦°×´¶À÷À­¡¦¹ü¿ñÀ­ºÙ˦Ãùα¾É¸õ·²¤ò¹çÊ»¤¹¤ëWHIM(¥¦¥¤¥à)¾É¸õ·²¤Ë»÷¤Æ¤¤¤ë¡£Í½¸åÉÔÎÉ¡¢Áá´ü¡Á¼ãÎð»àË´¡£2012ǯ¤Ë¼¯»ùÅçÂç³ØÂçϽ¤½Ã°å³ØÇî»Î¤é¤Î¸¦µæ(NCBI)
AR ¥Ü¡¼¥À¡¼
692 Vasculopathy
Ì®´É¾ã³²
* Ì®´É¤È¤Ïư̮¡¦ÀÅÌ®¡¦ÌÓºÙ·ì´É¤Î·ì´É¤È¡¢Æý¤Ó´É¡¦¥ê¥ó¥ÑÌӺٴɤΥê¥ó¥Ñ´É¤ÎÁí¾Î¡£ unknown *
695 Vitamin D-deficiency rickets, type I
¥Ó¥¿¥ß¥óD°Í¸À­¤¯¤ëÉ­µ·¿
ÍÄÎð´ü¤ÎÄ㥫¥ë¥·¥¦¥à·ì¾É¡¢¹ü¤Î¤¯¤ëÉÂÀ­ÊѲ½ ¥Ó¥¿¥ß¥óD¤ò³èÀ­²½¤¹¤ë¹ÚÁǤΰ۾³èÀ­·¿¥Ó¥¿¥ß¥óD¤¬»ºÀ¸¤µ¤ì¤Ê¤¤¤¿¤á¤Ëµ¯¤³¤ë¡£¤¯¤ëɤȤϹü´ð¼Á¤ÎÀг¥²½ÉÔÁ´¤Ë¤è¤Ã¤Æ¤ª¤³¤ëÉÂÂÖ¤ÎÁí¾Î¤Ç¹üÊÑ·Á¤ÈÀ®Ä¹¾ã³²¤ò¼çħ¤È¤¹¤ë¡£¼£ÎŤϳèÀ­·¿¥Ó¥¿¥ß¥óDÀ½ºÞ¤ÎÅêÍ¿ unknown *
696 Vitamin D-deficiency rickets, type II
¥Ó¥¿¥ß¥óD°Í¸À­¤¯¤ëÉ­¶·¿
Ʊ¾å Genes: VDR
¥Ó¥¿¥ß¥óD¼õÍÆÂΤΰ۾¤ª¤â¤ËƬÉô¤ËæÌÓ¤¬¸«¤é¤ì¤ë¡£¼£ÎŤϺ¤Æñ
ñ°ì°äÅÁ»Ò *
697 Vitamin-K-dependent blood coagulation factors deficiency
¥Ó¥¿¥ß¥óK°Í¸·¿·ì±Õ¶Å¸Ç°ø»Ò·ç˳¾É
* ­µ¤«¤é­¾­·¤Þ¤Ç¤Î·ì±Õ¶Å¸Ç°ø»Ò¤Ç¥Ó¥¿¥ß¥óK¤Ë¤è¤Ã¤ÆºîÍѤ¬Â¥¿Ê¤µ¤ì¤ë¤â¤Î¤Ï­¶¡¢­»¡¢­½¡¢­¾¡£¤³¤Î4¤Ä¤ò¥Ó¥¿¥ß¥óK°Í¸·¿·ì±Õ¶Å¸Ç°ø»Ò¤È¸À¤¦¡£¤³¤Î¼À´µ¤ÏIJÆâ¤Ç¤Î¥Ó¥¿¥ß¥óK¤Î¹çÀ®Äã²¼¤äµÛ¼ýÉÔÁ´¤Ç¤½¤ì¤é¤¬³èÀ­¤µ¤ì¤Ê¤¤¤¿¤á¤Ëµ¯¤³¤ë unknown *
699 Von Willebrand disease ­µ
¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ­µ·¿
* ¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¤ÎÎÌŪ·ç» AD¤« *
700 Von Willebrand disease ­¶
¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ­¶·¿
* Genes: VWF
¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¤Î¼ÁŪ·ç»
AD¤« *
701 Von Willebrand disease ­·
¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ­··¿
* ¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¤ÈÂè­¼°ø»Ò¤Î·ç˳¡£·ì¾®ÈÄÇ´Ãå¤È·ì±Õ¶Å¸Ç¤ÎξÊý¤Î°Û¾ï * AR¤« *
702 Von Willebrand disease, generic
¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥ÉÉ¡¢µ¶·ìͧÉÂ
·ì±Õ¶Å¸Ç°Û¾ï¡¢·ì¾®Èĵ¡Ç½¾ã³²¡¢¸ý¹ÐÆâ¡¦É¡·ì¤Ê¤ÉÇ´Ëì½Ð·ì¡¢½Ð·ì»þ´Ö±äĹ¡¢¥á¥¹¤Î±¢Éô½Ð·ì²á¿ ·ìÃævWf(¥Õ¥©¥ó¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¡á¶Å¸Ç°ø»Ò)¤Î·ç˳¤¬¸¶°ø¤Î·ì¾®ÈÄÇ´Ãå¾ã³²¤Ë¤è¤ëÀèÅ·À­½Ð·ìÀ­¼À´µ¡£¾ïÀ÷¿§ÂÎÀ­Í¥À­¤ÈÎôÀ­°äÅÁ¤¬¤¢¤ë¡£°ìÈÌŪ¤Ë½Ð·ì¤Ï·ÚÅÙ¡¢À®Ä¹¤¹¤ë¤Ë¤Ä¤ì¾É¾õ¤¬¤µ¤é¤Ë·Ú¤¯¤Ê¤ë¤³¤È¤â¤¢¤ë¡£vWf¤ÏÂè­¼°ø»Ò¤Î³èÀ­Éô¤È·ë¹ç¤·¤Æ´°Á´¤ÊÂè­¼°ø»Ò¤È¤Ê¤ê°ìÉôʬ¤Ç·ì¾®ÈĤòÇ´Ãå¶Å½¸¤µ¤»¤ë¡£·ìͧɤâÂè­¼°ø»Ò¤¬Äã²¼¤¹¤ë¤¬vWf¤ÏÀµ¾ï ¾ïÀ÷¿§ÂÎÀ­¡¢Ã±°ì°äÅÁ»Ò *





¡üÀèÅ·À­¶Å¸Ç°Û¾ï
Âè­µ°ø»Ò¤¬·ç˳¤¹¤ë¤È(°Ê²¼Æ±) ̵¥Õ¥£¥Ö¥ê¥Î¡¼¥²¥ó·ì¾É
Âè­¶ ¥×¥í¥È¥í¥ó¥Ó¥ó·ç˳¾É
Âè­· ¥«¥ë¥·¥¦¥à¡¦¥¤¥ª¥ó(·ç˳¥Ê¥·)
Âè­¸ *(·ç˳¥Ê¥·)
Âè­¹ ÉÔ°ÂÄê°ø»Ò·ç˳¾É(¥Ñ¥é·ìͧÉÂ)
Âè­º ·çÈÖ
Âè­» °ÂÄê°ø»Ò·ç˳¾É
Âè­¼ ·ìͧÉÂA
Âè­½ ·ìͧÉÂB
Âè­¾ ¥¹¥Á¥å¥¢¡¼¥È-¥×¥é¥¦¥¢¡¼°ø»Ò·ç˳¾É
Âè­¾­µ PTA·ç˳¾É
Âè­¾­¶ ¥Ï¡¼¥²¥Þ¥ó°ø»Ò·ç˳¾É
Âè­¾­· ¥Õ¥£¥Ö¥ê¥ó°ÂÄê²½°ø»Ò·ç˳¾É





¡ü·ì±Õ¡¡´ØÏ¢ÍѸì
·ì±Õ ¤±¤Ä¤¨¤­ blood ưʪ¤Î¼çÍפÊÂαա£µ¡Ç½¤Ï¡´ï¤Î°ì¼ï¡¢¹½Â¤Åª¤Ë¤Ï·ë¹çÁÈ¿¥¤Î°ì¤Ä¡£·ìµåÀ®Ê¬(ºÙ˦À­À®Ê¬)¤È·ìÞùÀ®Ê¬(±ÕÀ­À®Ê¬)¤«¤é¤Ê¤ë
¸¤¤Î·ì±Õ¤ÏÂνÅ1¥­¥í¤¢¤¿¤ê90¥ß¥ê¥ê¥Ã¥È¥ëÄø
·ìµå ¤±¤Ã¤­¤å¤¦ blood cell ·ì±ÕÃæ¤ÎºÙ˦À®Ê¬¤ÎÁí¾Î
Â礭¤¯ÀÖ·ìµå¡¢Çò·ìµå¤ª¤è¤Ó·ì¾®ÈÄ(Àòµå)¤Î3¤Ä¤Ëʬ¤±¤é¤ì¤ë
ÀÖ·ìµå ¤»¤Ã¤±¤Ã¤­¤å¤¦ Red blood cell
¤¢¤ë¤¤¤Ï
Erythrocyte
»ÀÁǤò±¿¤Ö·ì±ÕºÙ˦¤Î1¼ï
ÀÖ·ìµå¤Ï·ì±ÕºÙ˦¤Î°ì¤Ä¤Ç¿§¤ÏÀÖ¤¯·ì±Õ½Û´Ä¤Ë¤è¤Ã¤ÆÂÎÃæ¤ò²ó¤ê¡¢ÇÙ¤«¤éÆÀ¤¿»ÀÁǤò¥Ø¥â¥°¥í¥Ó¥ó¤Ë¼è¤ê¹þ¤ß¡¢ÂΤΤ¹¤ß¤º¤ß¤ÎºÙ˦¤Ë±¿¤Ó¶¡µë¤¹¤ëÌò³ä¤òô¤¤¡¢¤Þ¤¿Æó»À²½ÃºÁǤÎÇÓ½Ð¤Ë¤â´Ø¤ï¤ë
Çò·ìµå ¤Ï¤Ã¤±¤Ã¤­¤å¤¦ White blood cell
¤¢¤ë¤¤¤Ï
Leukocyte
Ëö¾¿·ìÆâ¤ÎÇò·ìµå¤ÏÄ̾¹¥Ãæµå¡¦¹¥»Àµå¡¦¹¥±ö´ðµå¡¦¥ê¥ó¥Ñµå¡¦Ã±µå¤Î5¼ïÎà
³°Éô¤«¤éÂÎÆâ¤Ë¿¯Æþ¤·¤¿ºÙ¶Ý¡¦¥¦¥¤¥ë¥¹¤Ê¤É°Ûʪ¤ÎÇÓ½ü¤È¼ðáçºÙ˦¡¦ÌòÌܤò½ª¤¨¤¿ºÙ˦¤ÎÇÓ½ü¤Ê¤É¤òÌò³ä¤È¤¹¤ë¤·ì´´ºÙ˦ͳÍè¤ÎºÙ˦
·ì¾®ÈÄ ¤±¤Ã¤·¤ç¤¦¤Ð¤ó Platelet ·ì´É¤¬Â»½ý¤·¤¿»þ¤Ë½¸¹ç¤·¤Æ¤½¤Î½ý¸ý¤ò¤Õ¤µ¤®(·ì¾®ÈĶŽ¸)¡¢½Ð·ì¤ò»ß¤á¤ëºîÍѤò»ý¤Ä¡¢³Ë¤ò»ý¤¿¤Ê¤¤ºÙ˦À®Ê¬
·ì¾®ÈĤϡ¢¹ü¿ñÃæ¤Îµð³Ëµå(µðÂç³ËºÙ˦)¤È¤¤¤¦ºÙ˦¤ÎºÙ˦¼Á¤¬¤Á¤®¤ì¤¿¤â¤Î¤Ç¡¢ºÙ˦¼Á¤Î¤ß¤«¤é¹½À®¤µ¤ì¤Æ¤ª¤ê¡¢³Ë¤ò»ý¤¿¤Ê¤¤¤Î¤Ç·Á¤âÉÔÄê·Á¤Ç¤¢¤ë¡£¼÷Ì¿¤¬¿Ô¤­¤ë¤È¼ç¤Ëç£Â¡¤ÇÇ˲õ¤µ¤ì¤ë
Ëö¾¿·ì ¤Þ¤Ã¤·¤ç¤¦¤±¤Ä Peripheral blood ·ì´É¤òή¤ì¤ëÄ̾ï¤Î·ì±Õ¤Î¤³¤È
¹ü¿ñ¡¢ç£Â¡¡¦´Î¡¤Ë¥×¡¼¥ë¤µ¤ì¤Æ¤¤¤ë·ì±Õ¤ä¡¢¥ê¥ó¥Ñ¡¢ÁÈ¿¥±Õ¡¢çÁÂÓ·ì¤Ê¤É¤È¶èÊ̤¹¤ë¤¿¤á¤ËËö¾¿·ì¤È¤¤¤¦
·ì±Õ¶Å¸Ç·Ï ¤±¤Ä¤¨¤­¤®¤ç¤¦¤³¤±¤¤ Blood coagulation ½Ð·ì¤ò»ß¤á¤ë¤¿¤á¤ËÀ¸ÂΤ¬·ì±Õ¤ò¶Å¸Ç¤µ¤»¤ë°ìÏ¢¤Îʬ»Ò¤ÎºîÍÑ·Ï
¥Õ¥©¥ó¡¦¥¦¥£¥ë¥Ö¥é¥ó¥É°ø»Ò¤ä¥È¥í¥ó¥Ó¥ó¤ä¥¢¥Ç¥Î¥·¥óÆó¥ê¥ó»À¡ÊADP¡Ë¤ä¾å¤Îɽ¤Î³Æ¶Å¸Ç°ø»Ò¤¬³èÌö¤¹¤ë¥á¥«¥Ë¥º¥à
ÀþÍÏ ¤»¤ó¤è¤¦ Fibronolysis °ìö¶Å¸Ç¤·¤¿·ì±Õ¡¦·ìÀò¤Ë¤è¤Ã¤ÆÊĺ¿¤µ¤ì¤Æ¤¤¤¿·ì´É¤¬ºÆ¤Ó³«Ä̤¹¤ë¥·¥¹¥Æ¥à¤Ç¡¢¤È¤¯¤Ë²ø²æ¤äɵ¤¤Ê¤É¤Ë¤è¤é¤ºÄ̾ï¤Î·ì´ÉÊɤǷìÀò¤Î·ÁÀ®¤ÈÀþÍϤÏÀ䤨¤º·«¤êÊÖ¤µ¤ì¤Æ¤¤¤ë¡£
¥Ò¥È¤Î½÷À­¤Î·î·Ð¤Ç¡¢·î·Ð·ì¤¬¶Å¸ÇÀ­¤ò¼º¤Ã¤Æ½Ð·ì¤¹¤ë¤Î¤Ï¤³¤Î¤¿¤á¡£


¤³¤Î¥Ú¡¼¥¸¤ÎÀèÆ¬¤ËÌá¤ë****** Á°¤Î¥Ú¡¼¥¸****** ¼¡¤Î¥Ú¡¼¥¸